🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: bionet.software
Article #2350

Identification of Druggable Sites for Protein-Protein Interaction Targets

#2350
From: Jim Prudhomme
Date: Wed, 02 Mar 2011 19:38
89 lines
4824 bytes
Cambridge Healthtech Institute & Bio-IT World Announce Upcoming Short
Course: 

Identification of Druggable Sites for Protein-Protein Interaction Targets
June 8, 2011 (6:00 - 9:00 p.m.)

Royal Sonesta Hotel Boston, Cambridge, MA

Register at https://chidb.com/register/2011/sbd/reg.asp

On June 8, 2011, a dinner short course (6:00 - 9:00 p.m.) will take place at
the conclusion of day one of CHI's Eleventh Annual Structure-Based Drug
Design 
conference. Delegates attending CHI's Structure-Based Drug Design conference
are invited to attend, as well as others from the local area.

 

About the course:

Despite the growing number of examples of small molecule inhibitors that
disrupt protein-protein interactions (PPIs), the origin of druggability 
is poorly understood. This course is designed to demonstrate the use of
computational methods to determine the most likely structure of the 
complex formed by interacting proteins, identify potentially druggable sites
in the interface, determine whether the target is druggable, and
provide information on potential ligands. Participants will study a number
of targets using web-based software (including PIPER and ClusPro, 
currently the best protein docking tools available) on their laptops. A
light dinner will be served.

 

Course Instructors:

Sandor Vajda, Ph.D., Professor, Departments of Biomedical Engineering and
Chemistry, Boston University

Dima Kozakov, Ph.D., Research Assistant Professor, Departments of Biomedical
Engineering, Boston University

 

.         The problem of disrupting protein-protein interactions 

.         Predicting the structure of protein-protein complexes using
fragment-based identification of binding hot spots 

.         Druggability of binding sites determined by the hot spots 

.         Identification of functional groups with preferential binding to
hot spots 

.         Comparison of computational and experimental approaches. 

 

Additional information and registration details for this course and
conference is available at http://www.healthtech.com/sbd
or call CHI at 781-972-5400.

A separate registration is required to attend the Structure-Based Drug
Design conference that is scheduled for June 6-8, 2011. 

If you would like to also attend the Structure-Based Drug Design conference,
you can save up to $350 if you register by
Friday, March 11.

 

Contact:

James Prudhomme

Cambridge Healthtech Institute

250 First Avenue, Suite 300

Needham, MA 02494

Phone: 781-972-5400

Fax: 781-972-5425

www.healthtech.com

 

 
Technical Details
Message-ID: <mailman.242.1299094560.20886.bio-soft@net.bio.net>
Path: arc1-ca.pugleaf.net!g2news2.google.com!news2.google.com!Xl.tags.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!local2.nntp.dca.giganews.com!news.giganews.com.POSTED!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: fa6b6,a21a19e052dbe686,start
X-Google-NewGroupId: yes
X-Google-Attributes: gid6710630482,domainid0,public,usenet
X-Google-Language: ENGLISH,ASCII-7-bit
Path: arc1-ca.pugleaf.net!g2news2.google.com!news2.google.com!Xl.tags.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!local2.nntp.dca.giganews.com!news.giganews.com.POSTED!not-for-mail
NNTP-Posting-Date: Wed, 02 Mar 2011 13:36:26 -0600
X-Envelope-From: jprudhomme@healthtech.com
From: "Jim Prudhomme" <jprudhomme@healthtech.com>
To: <Bio-soft@magpie.bio.indiana.edu>
Date: Wed, 2 Mar 2011 14:38:12 -0500
MIME-Version: 1.0
X-Mailer: Microsoft Office Outlook 12.0
Thread-Index: AcvZEUe3L5TvhD3LQH2Z7B1Sk5kknQAAAUCA
Content-Language: en-us
X-Originating-IP: [66.228.71.159]
X-AntiSpam: Checked for restricted content by Gordano's AntiSpam Software
X-Mailman-Approved-At: Wed, 02 Mar 2011 14:35:59 -0500
Content-Type: text/plain;
 charset="us-ascii"
Content-Transfer-Encoding: 7bit
X-Content-Filtered-By: Mailman/MimeDel 2.1.4
X-BeenThere: bio-soft@net.bio.net
X-Mailman-Version: 2.1.4
Precedence: list
Organization: BIOSCI/IUBio, Biology Dept., Indiana University
subject: Identification of Druggable Sites for Protein-Protein Interaction
 Targets
Newsgroups: bionet.software
Message-ID: <mailman.242.1299094560.20886.bio-soft@net.bio.net>
Approved: BIOSCI Approval Key <biosci-approval-key@net.bio.net>
X-Auth: PGPMoose V1.1 PGP bionet.software
 iQCVAwUBTW6cIaCIqsWvyF5FAQHL0wQAlVO7eqU/FnNViqpmrfk88qLKQiJ2M8+H
 ndae46/zv+KyO07DzcSk5CowY5ViM2fYmLWRu79Iti4ZQpPlVxjJbLRoWE4VKvZq
 9zJE7s/bC8JYGr3GpZXUJ/CAqqdYk5pP91Jq6gkiwfSwBHDQYa9ya/4YW9zHTqEt
 feHqrHV6DJ8= =+rGm
Lines: 90
X-Usenet-Provider: http://www.giganews.com
X-Trace: sv3-Z1QMAuZz6xux6CIDuMpjD2yovwzyZAoM6S0ncCftN02NqRL8hhX+t/f8ErZGiqJJJVpByfi4vCz03Cr!SKjdRm78VKijfwzbax6rPLN+QxJuAAGrETcSo3vrwBbnO83xzUOuGsQSpU1OIOxUQVBtxsRegaMm!o21WMg==
X-Complaints-To: abuse@giganews.com
X-DMCA-Notifications: http://www.giganews.com/info/dmca.html
X-Abuse-and-DMCA-Info: Please be sure to forward a copy of ALL headers
X-Abuse-and-DMCA-Info: Otherwise we will be unable to process your complaint properly
X-Postfilter: 1.3.40
X-Original-Bytes: 4533